Could an eye implant slow glaucoma vision loss? new trial underway.
NCT ID NCT02862938
First seen Nov 05, 2025 · Last updated May 15, 2026 · Updated 25 times
Summary
This study tests a tiny implant placed in the eye that releases helpful cells to protect vision in people with glaucoma. 54 participants will either get the implant or a sham procedure. Researchers will check if it slows vision loss and nerve damage over 6 months. This is an early-phase trial, so it focuses on safety and whether the approach works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Byers Eye Institute at Stanford University
Palo Alto, California, 94303, United States
Conditions
Explore the condition pages connected to this study.